AzTrials
AzTrials

Cancer SurvivorsNCT06867640

Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors

A study testing Forgiveness-Based Group Psychoeducation in people with Cancer Survivors, run by Hilal Merve Belen at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the effects of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric symptoms. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cancer Survivors
What is being tested?
Forgiveness-Based Group Psychoeducation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Apr 2025to 14 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written and verbal consent to participate in the study
  • Understanding and speaking Turkish
  • Being over 18 years old
  • Not having any visual, hearing or mental disabilities
  • Having been diagnosed with cancer, treated with curative intent and having completed major treatments (surgery, radiotherapy, chemotherapy) within the last 5 years

Who cannot join

  • Not volunteering to participate in research
  • Having a visual, hearing or mental disability
  • Agreeing to participate in another psychoeducational program conducted simultaneously with the research
  • Inability to communicate in Turkish
  • Having previously received training in forgiveness and/or coping with fear of relapse

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

  • Gülhane Health Sciences Institute

    Ankara, Keçiören, 06010

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors on Fear of Cancer Recurrence, Forgiveness and Psychiatric Symptoms: A Randomized Controlled Trial

This study aims to examine the effects of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric symptoms.

Read the detailed description

This study was designed as a randomized controlled experimental study with a pre-test-post-test and follow-up design to examine the effects of forgiveness-based group psychoeducation on fear of cancer recurrence, forgiveness and psychiatric symptoms of cancer survivors.

The aim is to evaluate the effects of a forgiveness-based psychoeducation program on cancer survivors. After the "Informed Voluntary Consent Form" is obtained from individuals who agree to participate in the study, the Introductory Information Form, Heartland Forgiveness Scale, Fear of Relapse Inventory and Brief Symptom Inventory will be applied. Pre-tests will be applied to the sample determined by an independent statistician. Then, participants will be divided into intervention and control groups by simple randomization method. Face-to-face forgiveness-based psychoeducation will be applied to the intervention group in 90-minute sessions once/twice a week, totaling 6 sessions. In the last session of psychoeducation, a post-test ("Introductory Information Form", "Heartland Forgiveness Scale", "Fear of Relapse Inventory" and "Brief Symptom Inventory") will be administered to both the intervention and control groups. The first follow-up test of the study will be administered to both the intervention and control groups 1 month after the post-test, and the second follow-up test of the study will be administered 3 months after the post-test. After the completion of the study and the measurements, it is planned to provide forgiveness-based psychoeducation to the participants in the control group.

Being tested
Forgiveness-Based Group Psychoeducation
Keywords
Cancer Survivors, Forgiveness, Psychoeducation, Fear of Cancer Recurrence, Quality of Life, Psychiatric Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Forgiveness-Based Group PsychoeducationOther

    The effect of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric conditions.

Study groups in NCT06867640
Study groupRoleWhat they receive
Forgiveness-Based Group PsychoeducationExperimentalForgiveness-based group psychoeducation to be conducted with the experimental group is planned as 6 sessions. The sessions are planned to be conducted in 3 groups of 8-10 people. The duration of a session is planned to be approximately 90 minutes. Group psychoeducation with the experimental group will be conducted face-to-face every week. The appropriate day for the sessions will be decided with the members of each group. The same group sessions will be conducted on the same day and time every week.
Receives: Other: Forgiveness-Based Group Psychoeducation
No InterventionNo interventionAfter the follow-up tests were completed, it was planned to implement the 6-session forgiveness-based group psychoeducation applied to the intervention group in the same way upon the request of the control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heartland Forgiveness Scale

    The scale, which evaluates the level of forgiveness and consists of 18 items, consists of three sub-dimensions: "forgiveness of self", "forgiveness of others" and "forgiveness of the situation". The items of the Likert-type scale are evaluated according to a 7-point evaluation scale and the evaluation is answered as "does not reflect me at all" (1 point), "does not reflect me very much" (3 points), "reflects me a little" (5 points) and "reflects me completely" (7 points). Items 2, 4, 6, 7, 9, 11, 13, 15 and 17 in the scale items are scored reversely. The scale is evaluated according to total and sub-scale scores and there is no cut-off score. High scores obtained from each of the sub-dimensions of the scale indicate a high or low level of forgiveness in the relevant sub-dimension. The total forgiveness score is formed by summing the scores of the sub-dimensions of the scale.

    Measured: Baseline, 6 th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)

Secondary outcomes (2)

  1. Brief Symptom Inventory

    It is a Likert-type scale and the items are scored by rating them between 0 and 4, with the statements "not at all" and "a lot". People who will fill out the scale are asked to read each item separately and indicate how much each of these symptoms has bothered them in the last week, including that day. When the total for each subscale is divided by the number of items in that subscale, a score for that dimension is obtained. Brief Symptom Inventory subscale dimensions and items; anxiety; items 12, 13, 28, 31, 32, 36, 38, 42, 43, 45, 46, 47, 49; depression; items 9, 14, 16, 17, 18, 19, 20, 25, 27, 35, 37, 39; negative self; Items 15, 21, 22, 24, 26, 34, 44, 48, 50, 51, 52, 53; somatization; items 2, 5, 7, 8, 11, 23, 29, 30, 33; hostality; items 1, 3, 4, 6, 10, 40, 41.

    Measured: Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)

  2. Fear of Cancer Recurrence Inventory

    The scale, which has a five-point Likert structure, consists of 42 items and 7 sub-dimensions. These sub-dimensions are; triggers (items 1-8 and 9-17), psychological distress (items 18-21), functional disorders (items 22-27), insight (items 28-30), self-relaxation methods (items 31-33), coping methods (items 34-42). The scale, which does not have any cut-off point, is scored as 0-4 points. It is obtained by adding the questions in each sub-dimension straight, except for question 43. The total scores that can be obtained from the scale are between 0-168, and as the score increases, it is judged that the fear of relapse increases.

    Measured: Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2025
  2. Study start2 Apr 2025
  3. Primary completion1 Jul 2025
  4. Study completion14 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Forgiveness-Based Group Psychoeducation
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06867640
Sponsor's protocol ID
LokmanHekimU-HMB-1
Status last verified
Feb 2025
First submitted
23 Feb 2025
Last updated
5 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Forgiveness-Based Group Psychoeducation in people with Cancer Survivors, run by Hilal Merve Belen at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heartland Forgiveness Scale (time frame: Baseline, 6 th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06867640.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in